Found 26 matching trials
KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer PHASE2 This phase II clinical trial is evaluating whether adding KRC-01 injections...
Show More Learn More & Join Trial
Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION) PHASE3 The study is a multicenter, open-label, randomized controlled clinical stud...
Show More Status
Active Not Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I) PHASE2 The goal of this clinical trial is to evaluate whether a total neoadjuvant ...
Show More Location
The Sixth Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer PHASE3 The goal of this clinical trial is to find out if adding a PD-1 antibody (s...
Show More Location
Sun Yat-Sen University Cancer Center
Learn More & Join Trial
Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer NA The SHAPERS study is a multicentre, open-label, randomised, pragmatic clini...
Show More Learn More & Join Trial
Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC PHASE2 Efficacy and safety of short-course radiotherapy in total neoadjuvant thera...
Show More Location
Hebei Medical University Fourth Hospital
Learn More & Join Trial
Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation PHASE2 This phase II trial compares the effect of irinotecan versus oxaliplatin af...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer PHASE2 Surgery is the primary treatment for rectal cancer. However, in patients wi...
Show More Location
The First Affiliated Hospital of Chongqing Medical University
Learn More & Join Trial
Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer PHASE2 To explore the complete response (CR) rate of modified short-course radioth...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
The Prognostic Impact Of The Neutrophil To Lymphocyte Ratio In Patients With Locally Advanced Rectal Cancer N/A In this study, we aim to investigate the prognostic value of pre-treatment ...
Show More Location
Multiple Locations
Learn More & Join Trial